Key facts
- Score direction
- Lower is better
- Meaningful change
- A change of 2 points on a 0-10 NRS is generally considered clinically meaningful for patient-reported symptom measures.
- Scoring
- Each of the four items is a standalone 0-10 numeric rating scale (NRS). Scores are stored directly from the slider response with no transformation or combined total. SPASTICITY: 0 = none, 10 = worst imaginable. PAIN: 0 =…
- Time to complete
- 3 min
- Licensing
- Available free of charge; Patient Watch charges only for platform services
About the Symptom check-in (NRS)
This check-in captures four common MS-related symptoms on standard 0-10 numeric rating scales (NRS). It is designed for frequent longitudinal tracking (for example weekly or bi-weekly) alongside periodic MSIS-29 assessments. Each symptom is charted independently so clinicians can see which domains are improving.
Medical Specialties
Anatomic Areas
Clinical Indications
Administration Instructions
Rate each symptom from 0 to 10, where 0 means none or no problems and 10 means the worst imaginable.
Scoring Methodology
Each of the four items is a standalone 0-10 numeric rating scale (NRS). Scores are stored directly from the slider response with no transformation or combined total. SPASTICITY: 0 = none, 10 = worst imaginable. PAIN: 0 = none, 10 = worst imaginable. SLEEP PROBLEMS: 0 = no problems, 10 = worst imaginable. FATIGUE: 0 = none, 10 = worst imaginable. Lower scores indicate fewer symptoms (better). There is no overall total score; each subscore is reported and charted separately.
Meaningful Change Threshold
A change of 2 points on a 0-10 NRS is generally considered clinically meaningful for patient-reported symptom measures.
Score Interpretation
Understanding what your score means
minimal
0 - 2Minimal or no symptom burden.
mild
3 - 4Mild symptoms that may not interfere with daily activities.
moderate
5 - 6Moderate symptoms that interfere with some activities.
severe
7 - 8Severe symptoms that interfere with most activities.
worst
9 - 10Worst imaginable symptom level.
Subscales
This questionnaire measures multiple dimensions
Pain(0-10)
Self-reported pain severity.
Sleep problems(0-10)
Self-reported sleep disturbance.
Fatigue(0-10)
Self-reported fatigue severity.
Spasticity(0-10)
Self-reported spasticity severity.
Clinical Limitations & Considerations
These are single-item NRS measures and do not replace comprehensive PROMs such as MSIS-29. Scores depend on patient understanding, recall, and current mood. Each symptom should be interpreted independently rather than averaged into a single index.
Frequently asked questions
What does a mild Symptom check-in (NRS) score mean?
A Symptom check-in (NRS) score of 3 to 4 is classified as mild. Mild symptoms that may not interfere with daily activities.
What does a worst Symptom check-in (NRS) score mean?
A Symptom check-in (NRS) score of 9 to 10 is classified as worst. Worst imaginable symptom level.
What does a severe Symptom check-in (NRS) score mean?
A Symptom check-in (NRS) score of 7 to 8 is classified as severe. Severe symptoms that interfere with most activities.
What does a minimal Symptom check-in (NRS) score mean?
A Symptom check-in (NRS) score of 0 to 2 is classified as minimal. Minimal or no symptom burden.
What does a moderate Symptom check-in (NRS) score mean?
A Symptom check-in (NRS) score of 5 to 6 is classified as moderate. Moderate symptoms that interfere with some activities.
Related Outcome Measures
Other clinical questionnaires for similar specialties and conditions
Multiple Sclerosis Impact Scale (MSIS-29)
A 29-item patient-reported measure of the physical (20 items) and psychological (9 items) impact of multiple sclerosis over the past two weeks.
MS Profile
A short demographic form to capture multiple sclerosis type and years since diagnosis.
Clinician and Organisation
Captures the treating neurologist and organisation.
This questionnaire is provided free of charge. Patient Watch charges only for platform services (data storage, automated reminders, analytics) - not for use of clinical instruments. This non-commercial model supports academic and clinical use.View full licensing disclosure